ClinicalTrials.gov
ClinicalTrials.gov Menu

BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00095459
Recruitment Status : Completed
First Posted : November 5, 2004
Last Update Posted : April 20, 2018
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)